Japanese encephalitis vaccines first became available in the 1930s. [3] One of them was an inactivated mouse brain-derived vaccine (the Nakayama and/or Beijing-1 strain), made by BIKEN and marketed by Sanofi Pasteur as JE-VAX, until production ceased in 2005. The other was an inactivated vaccine cultivated on primary hamster kidney cells (the ...

Aug 4, 2021 · JE-VAX®, Japanese Encephalitis Virus Vaccine Inactivated, is a sterile, lyophilized vaccine for subcutaneous use, prepared by inoculating mice intracerebrally with Japanese encephalitis (JE) virus, "Nakayama-NIH" strain, manufactured by The Research Foundation for Microbial Diseases of Osaka University ("BIKEN ® buffered saline, pH 8.0. The ...

May 15, 2024 · One Japanese encephalitis vaccine (called IXIARO) is available in the United States. Japanese encephalitis vaccine is approved for use in children aged 2 months and older and adults. The vaccine should be considered for some travelers at higher risk of Japanese encephalitis. IXIARO is given as a two-dose series, with the doses spaced 28 days apart.

The JEV vaccine prevents Japanese encephalitis virus infections. This infection results from a mosquito bite. Your provider may recommend this vaccine if you’re traveling to Asia or the western Pacific, and plan to stay for more than four weeks.

Sep 9, 2024 · JE-VC (manufactured as IXIARO) is the only JE vaccine licensed and available in the United States. JE-VC is manufactured by Valneva Austria GmbH. In March 2009, the US Food and Drug Administration (FDA) licensed JE-VC for use in adults aged ≥17 years.

May 15, 2024 · One inactivated Japanese encephalitis (JE) vaccine (manufactured as IXIARO) is available in the United States. JE vaccine is approved for use in children aged 2 months and older and adults. JE is a very low risk disease for most travelers.

IXIARO® is a purified, inactivated aluminum-adjuvanted JE vaccine, based on the SA14–14–2 virus strain, and is available in North America, Europe, Canada, Switzerland, Singapore, Hong Kong and Israel as well as in Australia & New Zealand (as JESPECT®).The safety, tolerability and immunogenicity profile of IXIARO® is well established through a nu...

Aug 14, 2024 · 嵌合疫苗(Chimeric Vaccine, ChimeriVax-JE)是将SA-14-14-2的前质膜(Precursor Membrane, prM)和包膜(Envelope, Env)基因插入黄热病17D病毒“骨干”中，形成减毒活疫苗。 此外，在临床前研究中有几种基于不同策略的候选疫苗，包括DNA疫苗、肽和蛋白质亚单位疫苗、复制 …

Inactivated Vero cell culture–derived JE vaccine (Ixiaro [JE-VC]) is the only JE vaccine that is licensed and available in the United States. An inactivated mouse brain–derived vaccine (JE-VAX [JE-MB]) has been licensed in the United States since 1992 but is no longer produced, and all remaining doses expired in 2011.

Japanese encephalitis (JE) is a serious public health concern in most of Asia. The disease is caused by JE virus (JEV), a flavivirus transmitted by Culex mosquitoes. Several vaccines have been developed to control JE in endemic areas as well as to protect travelers and military personnel who visit or are commissioned from non-endemic to endemic ...